TABLE 2

Patients’ Age and Global Parameters in NC, DCM, and HCM

Parameter	NC (n = 5)	DCM			HCM
Parameter	NC (n = 5)	Non-HF (n = 8)	HF (n = 7)	Overall (n = 15)	Non-DP (n = 14)	DP (n = 4)	Overall (n = 18)
Age (y)	47.6 ± 12.68	58.38 ± 15.45	58.14 ± 9.6	58.27 ± 12.6	55.93 ± 19.08	60.25 ± 6.80	56.89 ± 17.03
LVEF (%)	71 ± 11.22	33.5 ± 7.84*	22 ± 8.35*†	28.13 ± 9.79*	50.29 ± 10.82*	37.75 ± 1.5*‡	47.5 ± 10.9*§
H/M-TF	2.92 ± 0.54	2.62 ± 0.31	2.46 ± 0.46	2.55 ± 0.38	3.32 ± 0.51	2.92 ± 0.33	3.23 ± 0.5§
H/Me	2.17 ± 0.05	1.89 ± 0.34	1.8 ± 0.18*	1.85 ± 0.27*	2.39 ± 0.33*	1.91 ± 0.20‡	2.28 ± 0.36§
H/Md	2.66 ± 0.21	1.91 ± 0.48*	1.73 ± 0.39*	1.82 ± 0.44*	2.36 ± 0.29	2.03 ± 0.29*	2.28 ± 0.31*§
GW (%)	11.88 ± 7.23	33.34 ± 9.02*	31.58 ± 11.18*	32.52 ± 9.75*	26.47 ± 7.01*	23.64 ± 10.34	25.84 ± 7.61*§

↵* P < 0.05 vs. NC.
↵† P < 0.05 vs. non-HF.
↵‡ P < 0.05 vs. non-DP.
↵§ P < 0.05 vs. DCM (overall).
n = case number; Non-HF = nonheart failure; HF = heart failure; Non-DP = nondilated phase; DP = dilated phase; H/M-TF = H/M in tetrofosmin study; H/Me = early H/M in MIBG study; H/Md = delayed H/M in MIBG study.
Data are presented as mean ± SD.